Drug Profile
AD-GL0002
Latest Information Update: 25 May 2006
Price :
$50
*
At a glance
- Originator ActinoDrug Pharmaceuticals
- Class Small molecules
- Mechanism of Action Interleukin 6 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Liver disorders; Parkinson's disease
Most Recent Events
- 25 May 2006 No development reported - Preclinical for Cancer in Germany (unspecified route)
- 25 May 2006 No development reported - Preclinical for Liver disorders in Germany (unspecified route)
- 25 May 2006 No development reported - Preclinical for Parkinson's disease in Germany (unspecified route)